Corrigendum: The value of second-line anti-HER2 therapy in metastatic HER-2 positive patients: a cost-effectiveness analysis in China

Saved in:
Bibliographic Details
Main Authors: Lu Li, Shilei Yang, Fengqi Fang, Li Tian, Ying He, Jia Li, Yanwei Chen, Deshi Dong
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1519505/full
Tags: Add Tag
No Tags, Be the first to tag this record!